Evidence map›Paper›PMID 41995489›Full record

ArticleMedicine2026

Right atrial rupture caused by primary cardiac angiosarcoma: A case report.

Haoxian Lai, Liya Wei

Abstract readCase Reports
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Haoxian LaiGuangdong Medical University, Zhanjiang, China.ORCID 0009-0000-5685-7415
Liya WeiGuangdong Medical University, Zhanjiang, China.

Funding

Shenzhen Science and Technology Innovation Commission JCYJ20210324105614038
6 · The paper itself

Abstract

rationalePrimary cardiac angiosarcoma is a rare malignant neoplasm of the heart. Clinical manifestations typically occur at an advanced stage, rendering early diagnosis challenging. Herein, we present the case of a young female patient with cardiac angiosarcoma complicated by atrial rupture. PATIENT CONCERNS: The patient was a young woman who was admitted to the hospital after a sudden episode of syncope with loss of consciousness. Transthoracic echocardiography revealed a solid mass located in the anterolateral wall of the right atrium, accompanied by a large amount of pericardial effusion. Computed tomography and magnetic resonance imaging findings were suggestive of cardiac angiosarcoma. Consequently, the patient underwent resection of the malignant cardiac tumor and repair of cardiac rupture. Histopathological examination demonstrated tumor cells with abundant eosinophilic cytoplasm. Immunohistochemical analysis showed that the tumor cells were positive for CD31 and ERG. DIAGNOSES: Based on the clinical presentation, imaging findings, and immunophenotypic evidence, the patient was diagnosed with primary cardiac angiosarcoma.

interventionsThe patient received regular postoperative chemotherapy. OUTCOMES: After regular follow-up for 8 months, the patient was transferred to continue chemotherapy and died due to multiple metastatic tumors. LESSONS: Primary cardiac angiosarcoma is a rare malignant cardiac tumor. Because clinical manifestations usually occur at an advanced stage, early diagnosis remains challenging. The comprehensive use of multiple imaging modalities is beneficial for accurate lesion identification, tumor staging, and thorough disease evaluation.

Indexed as

Heart AtriaHeart NeoplasmsHeart RuptureHemangiosarcomaAdultEchocardiographyFatal OutcomeFemaleHumansMagnetic Resonance ImagingPericardial EffusionTomography, X-Ray Computedcase reportcolor Dopplerprimary cardiac angiosarcoma

Identifiers

PMID41995489
PMCPMC13095266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.